Search Thermo Fisher Scientific
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Cugrastomig is a bispecific antibody that targets both LAG-3 and PD-1 key immune checkpoints. It works by enhancing T-cell activity to combat tumors and is undergoing clinical trials for cancers like non-small cell lung cancer and colorectal adenocarcinoma.
仅用于科研。不用于诊断过程。未经明确授权不得转售。